Overview
Nublexa 40 mg contains Regorafenib, a multikinase inhibitor used in the treatment of advanced cancers, including metastatic colorectal cancer (mCRC), gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma (HCC). It works by blocking multiple enzymes (kinases) that promote cancer cell growth and blood supply to tumors, thereby inhibiting tumor progression.





